7XZ-21174-63938
4 vaccinations
1 coded response
15 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 020 / MA
- Registered
- 2021-05-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Moderna
-
2021-05-03
Registered in v-safe
- 2021-05-03
-
2021-05-07
Dose 2 — Moderna
-
2021-05-07
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-16
- 2021-05-21
- 2021-05-28
- 2021-06-11
- 2021-08-09
- 2021-11-05
-
2021-11-14
Dose 3 — Moderna
-
2022-05-07
Survey response — 12 months, dose 2MedDRA: COVID-19, Exposure to SARS-CoV-2, Pregnancy, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid (April 9th exposure, 12th first positive test) + first trimester pregnancy symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-09
-
2022-08-26
Dose 4 — Moderna
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Moderna | |
| 2 | 2021-05-07 | Moderna | |
| 3 | 2021-11-14 | Moderna | No |
| 4 | 2022-08-26 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-07 | Unsuccessful |
Free text
Release 11 — 12 months, dose 2
Symptoms: Covid (April 9th exposure, 12th first positive test) + first trimester pregnancy symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release